Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment

Figure 7

PLK1 inhibition increases MHC class I expression in cell lines. (a) qPCR analysis of MHC class I mRNA expression in pre- and post- treated cell lines with BI2536. (b) Flow cytometric analysis of MHC class I (HLA-ABC, W6/32 labeling) expression on pre- and post- treated cell lines with BI2536.